Syntellix AG is a pioneering medical technology company specializing in the research, development, manufacturing, and sales of bioabsorbable metallic implants. Their flagship product, MAGNEZIX®, is a revolutionary material that combines the stability of metal with the ability to be fully absorbed and replaced by the body's own bone tissue over time. This innovation eliminates the need for secondary surgeries to remove implants, reducing patient risk and healthcare costs.
Key Features and Functionality:
- Bioabsorbable Metallic Composition: MAGNEZIX® implants provide the mechanical stability of traditional metal implants while being fully resorbed by the body, transforming into natural bone tissue.
- Osteoconductive Properties: The material promotes bone growth, facilitating faster and more efficient healing processes.
- Infection Inhibition: MAGNEZIX® has inherent properties that help reduce the risk of post-operative infections.
- Regulatory Approvals: The implants have received CE certification in Europe and approval from Singapore's Health Sciences Authority (HSA), reflecting their safety and efficacy.
Primary Value and User Benefits:
Syntellix's MAGNEZIX® implants address several critical challenges in orthopedic and trauma surgery. By eliminating the need for secondary removal surgeries, they reduce patient discomfort, lower the risk of complications such as infections and bone loss, and decrease overall healthcare costs. The bioabsorbable nature of the implants ensures that no foreign material remains in the body, leading to more natural healing and better long-term outcomes for patients.
